Disclosures. Serial Tes+ng for TB Infec+on with IGRAs: Understanding the Sources of Variability. Stanford Hospital Policy
|
|
- Jerome Cain
- 5 years ago
- Views:
Transcription
1 Serial Tes+ng for TB Infec+on with IGRAs: Understanding the Sources of Variability Disclosures Banaei: No financial conflicts No industry links or funding Niaz Banaei MD Assistant Professor of Pathology and Medicine Director, Clinical Microbiology Laboratory Stanford University Medical Center Stanford Hospital Policy - Screen new HCW and then annually - >10,000 screenings per year CDC guidelines in 2005 recommended use of IGRAs for HCW screening with: no published data on serial tes+ng no independent, peer- reviewed literature on IGRA reproducibility Simplis+c neg to pos change was defined as conversion (since there were no data) Sensitivity in patients with latent TB using progression to active TB as gold standard CDC guidelines in 2005 recommended use of IGRAs for HCW screening with: no published data on serial tes+ng no independent, peer- reviewed literature on IGRA reproducibility Simplis+c neg to pos change was defined as conversion (since there were no data) Herrera et al CID
2 Since 2006, >50 studies have assessed IGRAs in HCWs Reproducibility of QFT- IT in HCW Thorax 2012 Coversions 2% to 15% Reversions 20 to 40% Largest study of >2000 HCWs (CDC Task Order 18 study): TST = 0.9 % QFT = 6.1% T-SPOT = 8.3% conversion rates Canadian study in HCWs (Zwerling et al. PLoS ONE 2013): TST = 0 % QFT = 5.3% conversion rates Pai and Elwood Can Respir J Trajectory plots of IFN-gamma over 4 test points 960 valid QFT results (HCWs in India tested with QFT every 6 months x 4 times) Early adopters of IGRAs for HCW screening in the US are reporting interesting challenges (and different hospitals are coming up with their own interpretational criteria and cut-offs!) Zwerling A et al. Under review Need to Identify Sources of IGRA Variability Reproducibility studies are now emerging (independent of manufacturers) - Eliminate - Standardize - Account for variability 2
3 Sources of IGRA Variability Quantiferon Gold Intube Assay Pre-analytical Analytical Nil TBAg Mit Manufacturing Immunological Assay cut-off 0.35 IU/ml QFT- GIT Assay Standardiza+on Standardized Not Standardized - Skin disinfection - Blood volume - Shaking of tubes - T cell and APC count - Transportation temp - Diet - Incubation delay - Infection - Incubation temp - Antibiotics - Incubation duration - Plasma separation delay - Plasma storage - Analytical - ELISA QFT- GIT Assay Standardiza+on Standardized Not Standardized - Skin disinfection - Blood volume - Shaking of tubes - T cell and APC count - Transportation temp - Diet - Incubation delay - Infection - Incubation temp - Antibiotics - Incubation duration - Plasma separation delay - Plasma storage Does Blood Volume Matter? - Draw ml of blood - Analytical - ELISA 3
4 Effect of Blood Volume on TB Response Distribution of Blood Volume in QFT Tubes Infected Group (TST+ QFT+) n=13 P = P = Uninfected Group (TST- QFT-) n=18 Median: Range: CV: 3.8% 3.3% 0.8 ml 1.0 ml 1.2 ml <0.35 2(15%) 5 (39%) 7 (54%) ml 1.0 ml 1.2 ml < Gaur et al unpublished Effect of Shaking on TB Response Does Shaking Matter? P=0.058 Nil P=0.39 TB Ag Nil TBAg Mit P=0.5 Vigorous n=10 n=10 Vigorous Assay cut-off 0.35 IU/ml Vigorous n=10 Does Incubation Delay Matter? Effect of Incubation Delay on IGRA - Transport to incubator ( 16h) Hanekom et al 2004 J. Immunol. Methods 4
5 Effect of Incubation Delay on the Accuracy of QFT-IT Results TB Response Following Immediate and Delayed Incubation 128 study participants 3 QFT-GIT sets collected Low risk & - TST&orQFT High risk & + TST&orQFT Incubation Delay 0 h 6 h 12 h Doberne et al JCM 2011 n=128 Doberne et al JCM 2011 TB Response for Subjects with Discordant Results Mitogen Results Following Incubation Delay Reversion rate: 19% (5/26) with 6 h delay 22% (5/23) with 12 h delay Doberne et al JCM 2011 Doberne et al JCM 2011 Effect of Incubation Delay on Determinate Results Mitogen Results Following Incubation Delay Herrera et al JCM 2010 Herrera et al JCM
6 Incubation Delay Increases Indeterminate Results Does Incubation Duration Matter? C h Herrera et al JCM 2010 Effect of Incubation Duration on TB Response QFT- GIT Assay Standardiza+on 16 hr 20 hr 24 hr < Infected Group (TST+ QFT+) n=13 Uninfected Group (TST- QFT-) n=18 16 hr 20 hr 24 hr < Gaur et al unpublished Standardized Not Standardized - Skin disinfection - Blood volume - Shaking of tubes - T cell and APC count - Transportation temp - Diet - Incubation delay - Infection - Incubation temp - Antibiotics - Incubation duration - Plasma separation delay - Plasma storage - Analytical - ELISA Analy+cal Precision of QFT- GIT Assay QFT- GIT Assay Standardiza+on Standardized Not Standardized - Skin disinfection - Blood volume - Shaking of tubes - T cell and APC count - Transportation temp - Diet - Incubation delay - Infection - Incubation temp - Antibiotics - Incubation duration - Plasma separation delay - Plasma storage Detjen et al Clin Vaccine Immunol Analytical - ELISA 6
7 Analy+cal Precision of QFT- GIT Assay Analy+cal Precision of QFT- GIT Assay Detjen et al Clin Vaccine Immunol 2009 Metcalfe et al AJRCCM 2012 Whitworth et al JCM Qualitative results: High agreement (kappa 0.84) - Quantitative results: Considerable between-run variability (CV 14% for all and CV 27% for borderline ( IU/ml) - 86% (24/28) of discordants had borderline result ( IU/ml) Metcalfe et al AJRCCM 2012 Analy+cal Imprecision of QFT- GIT Assay: Between- Run Variability (n=20 ELISA runs) Sources of IGRA Variability Borderline Negative Sample Borderline Positive Sample Pre-analytical Analytical Manufacturing Immunological CV 14% CV 11% Conversion 10% (2/20) Reversion 20% (4/20) The QFT-GIT Surveillance Graph: Daily Positive Rate Mar-Oct 2010 The QFT-GIT Surveillance Graph Showing Daily Positive Rate at Stanford Positive Rate Mar 3-Mar 5-Mar 10-Mar 7-Mar 12-Mar 15-Mar 18-Mar 20-Mar 23-Mar 25-Mar 27-Mar 30-Mar 1-Apr 3-Apr 7-Apr 11-Apr 9-Apr 13-Apr 15-Apr 18-Apr 20-Apr 22-Apr 25-Apr 27-Apr 29-Apr 2-May 5-May 10-May 7-May 12-May 15-May 18-May 20-May 23-May 25-May 27-May 29-May 31-May 2-Jun 4-Jun 6-Jun 11-Jun 9-Jun 13-Jun 16-Jun 18-Jun 20-Jun 22-Jun 25-Jun 27-Jun 29-Jun 1-Jul 3-Jul 5-Jul 7-Jul 13-Jul 9-Jul 15-Jul 18-Jul 20-Jul 22-Jul 24-Jul 26-Jul 28-Jul 1-Aug 3-Aug 5-Aug 11-Aug 8-Aug 13-Aug 15-Aug 18-Aug 20-Aug 23-Aug 26-Aug 28-Aug 31-Aug 2-Sep 5-Sep 12-Sep 9-Sep 15-Sep 17-Sep 19-Sep 21-Sep 23-Sep 26-Sep 28-Sep 30-Sep 2-Oct 4-Oct 6-Oct 8-Oct Positive rate cot-11 4-Oct-11 5-Oct-11 6-Oct-11 Elevated rate noted 7-Oct-11 9-Oct Oct Oct Oct Oct Oct Oct Oct Oct Oct Oct Oct Oct Oct Oct Oct Oct Oct-11 1-Nov-11 2-Nov-11 3-Nov-11 4-Nov-11 6-Nov-11 8-Nov-11 9-Nov Nov Nov Nov Nov Nov Nov Nov Nov Nov Nov Nov Nov Nov Nov Nov-11 1-Dec-11 2-Dec-11 4-Dec-11 TBAg lot discontinued 5-Dec-11 6-Dec-11 7-Dec-11 8-Dec-11 9-Dec Dec Dec Dec Dec 'Dec Dec Dec Dec Dec Dec Dec Dec Dec Dec-11 7
8 Within-subject Comparison of QFT-GIT Results 31% vs 5% n=463 FDA informed via CDC. Investigation Outcomes Cellestis conducted an internal investigation and could not reproduce our findings. We could not culture viable organisms. Slater et al JCM 2012 Sources of IGRA Variability Pre-analytical Analytical Manufacturing Immunological van Zyl-Smit et al AJRCCM 2009 Amnestic Response to PPD Role of PAMPs in Modulating IGRA IGRA Boosting by PPD - PPD contains RD1 antigens - In TST+ subjects - Observed >3 days post TST TB Response Lymphoid Tissue PAMPs IL-12 + APC Th 0 Th 1 _ IFN-γ Th 2 CD 4 IFN-γ + APC ESAT6 CFP-10 TB7.7 RD1 antigens present in PPD van Zyl-Smit et al PLoS ONE 2009 Ritz et al Ritz Int J Tuberc Lung Dis 2011 Sauzullo et al Tuberculosis 2011 Site of Infection Th 1 IFN-γ + TNF-α Mφ Mogensen Clin Mic Rev
9 Recognition of Different PAMPs by PRRs TLR Agonists Activate Adaptive Immune Responses LPS Naïve T-cell activation Antigen presentation Corss-presentation Cell recruitment DC maturation: Costimulatory molecules, MHC Mogensen Clin Mic Rev 2009 Role of PAMPs in Modulating IGRA PAMPs APC Lymphoid Tissue IL-12 + Th 0 Th 1 _ IFN-γ Th 2 Site of Infection PAMPs Th 1 IFN-γ + TNF-α Mφ Mogensen Clin Mic Rev 2009 Effect of Microbiota on IGRA Response CD 4 PAMPs IFN-γ + APC ESAT6 CFP-10 TB7.7 Iwasaki & Medzhitov Nat Immun
10 PAMPs Increase TB Response in QFT-IT Assay Healthy Controls Subjects with LTBI Poly(I:C) & LPS Induce Inflammatory Cytokines & IFN-α in Whole Blood in QFT Nil Tube N=10 per grup Gaur et al PLoS One 2012 N=8 LPS Induce Maturation of Monocytes in Whole Blood in QFT Nil Tube PAMPS Triger Earlier and Greater IFN-γ Release PAMPs Enhance Response in High Risk Subjects Role of PAMPs in Modulating IGRA PAMPs APC Lymphoid Tissue IL-12 + Th 0 Th 1 _ IFN-γ Th 2 Site of Infection PAMPs Th 1 IFN-γ + TNF-α Mφ Mogensen Clin Mic Rev
11 SHC Blood Culture Monthly Contamination Rate Clarke et al Nat Med 2010 Ichinohe et al PNAS 2011 Skin Flora and Antisepsis Stanford Medical Center Blood Culture Contamination Rate Hair Follicle Bacteria Effect of Microbiota on IGRA Response CD 4 Skin Biota IFN-γ + APC ESAT6 CFP-10 TB7.7 Conclusions and sugges+ons Exis+ng guidelines for HCW screening needs to be revised We need to ask if so many low risk HCWs need repeated screening We should avoid tes+ng low risk people If we do test them, we will need to deal with false- posi+ve results Should the $$ be invested in controlling TB in high burden countries instead? Companies, health ins+tu+ons and labs must do everything they can to standardize tes+ng protocols, to minimize varia+on IGRA manufacturers should consider +ghtening the ranges in the current product insert (e.g. +me to incuba+on) 11
12 Conclusions and sugges+ons We need to rethink the cut- offs for serial tes+ng and for diagnosis Simple neg to pos cut- offs are no longer acceptable We must start interpre+ng con+nuous IGRA results (like TST) We need a borderline zone or some other strategy (e.g. re- tes+ng) to handle conversions and reversions We may need to go back and rethink the diagnos+c cut- off To derive beher cut- offs, we need to es+mate all the sources of varia+on, and compute the overall expected random varia+on Aier doing this, we need to figure out the sens/spec of the new cut- offs Stanford University Victor Herrera Rajiv Gaur David Doberne Mady Slater Julie Parsonnet Acknowledgements: Banaei UCSF/Hanoi Payam Nahid Adithya Cattamanchi Minh-Chi Tran Financial Support Stanford Pathology Stanford SPARK/ Global Health McGill University Madhukar Pai 12
Updated CDC Guidelines for Interferon Gamma Release Assays
TB Intensive San Antonio, Texas August 2-5, 2011 Updated CDC Guidelines for Interferon Gamma Release Assays Lisa Armitige, MD, PhD August 4, 2011 Lisa Armitige, MD, PhD has the following disclosures to
More informationIGRAs for Serial Testing of Healthcare Workers
IGRAs for Serial Testing of Healthcare Workers Jason Stout, MD, MHS Wake County TB Medical Consultant NC TB Medical Director Division of Infectious Diseases, Duke University Medical Center Disclosures-Funding
More informationJohn Metcalfe, MD, MPH Division of Pulmonary and Critical Care Medicine, San Francisco General Hospital, and Curry International Tuberculosis Center
WITHIN TEST TEST VARIABILITY OF THE QUANTIFERON TB TB GOLD IN TUBE ASSAY IN A LARGE COHORT OF LOW RISK SUBJECTS John Metcalfe, MD, MPH Division of Pulmonary and Critical Care Medicine, San Francisco General
More informationIGRA: Diagnosing TB in the Twenty-First Century with. Peter Barnes, MD
TB Intensive Tyler, Texas June 2-4, 2010 IGRA: Diagnosing TB in the Twenty-First Century with Case Studies Peter Barnes, MD June 4, 2010 Interferon Gamma Releasing Assays: Diagnosing TB in the Twenty-First
More informationScreening children for TB in Europe. Professor Beate Kampmann FRCPCH, PhD. Imperial College, London & MRC Unit- The Gambia
Screening children for TB in Europe Professor Beate Kampmann FRCPCH, PhD Imperial College, London & MRC Unit- The Gambia 21. Tuberkulose-Symposium Mu nchenwiler 22. Ma rz 2012 Acknowledgement Presentation
More informationLTBI Testing: Areas of Concern and Gray Zones
LTBI Testing: Areas of Concern and Gray Zones June 2, 2015 Masa Narita, MD Outline Positive Predictive Value LTBI testing in the general population Reproducibility Boosting Positive Predictive Value The
More informationChanging the way the world looks at TB
Changing the way the world looks at TB QuantiFERON -TB Gold www.quantiferon.com Identifying TB Infection is essential Tuberculosis (TB) remains a significant threat to humanity. At least one billion people
More informationSupplementary webappendix
Supplementary webappendix This webappendix formed part of the original submission and has been peer reviewed. We post it as supplied by the authors. Supplement to: Gao L, Lu W, Bai L, et al, for the LATENTTB-NSTM
More informationInterferon Gamma Release Assays (IGRAs) for the Diagnosis of Latent Tuberculosis Infection. Conflict of interest statement.
Interferon Gamma Release Assays (IGRAs) for the Diagnosis of Latent Tuberculosis Infection Conflict of interest statement I have performed, and am currently performing, studies using the T-Spot. TB IGRA
More informationDIAGNOSIS OF TB D R. K O N G P O M A R N K O N G C L I N I C F O R C H E S T & I N T E R N A L M E D I C I N E
DIAGNOSIS OF TB D R. K O N G P O M A R N K O N G C L I N I C F O R C H E S T & I N T E R N A L M E D I C I N E PATHOGENESIS OF TB INFECTION AND DISEASE (I) PATHOGENESIS OF TB INFECTION AND DISEASE (II)
More informationTB Intensive San Antonio, Texas December 1-3, 2010
TB Intensive San Antonio, Texas December 1-3, 2010 Updated CDC Guidelines for Interferon Gamma Release Assays Phil LoBue, MD, FACP, FCCP; CDC December 1, 2010 Update on Interferon-γ Release Assays Philip
More informationEVALUATION OF LATENT TUBERCULOSIS INFECTION SCREENING IN THE FIELD
EVALUATION OF LATENT TUBERCULOSIS INFECTION SCREENING IN THE FIELD Gema Morales Meyer DNP, RN, APHN BC, CNS Penny Weismuller DrPH, RN Presenter Disclosures Gema Morales Meyer DNP, RN, APHN BC, CNS The
More informationDiagnosis of Latent TB Infection
Diagnosis of Latent TB Infection Patricio Escalante, MD, MSc, FCCP Division of Pulmonary and Critical Care Medicine Mycobacterial and Bronchiectasis Clinic Olmsted County Tuberculosis Clinic Mayo Clinic
More informationOperational Issues with Implementation of QuantiFERON TB Gold Testing in Iowa. Michael Pentella, Ph.D., D(ABMM), CIC University Hygienic Lab
Operational Issues with Implementation of QuantiFERON TB Gold Testing in Iowa Michael Pentella, Ph.D., D(ABMM), CIC University Hygienic Lab http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5711a2.htm How did
More informationTwo Interferon Gamma Release Assays and Tuberculin Skin Test in the diagnosis of Mycobacterium tuberculosis infection and disease in The Gambia
Two Interferon Gamma Release Assays and Tuberculin Skin Test in the diagnosis of Mycobacterium tuberculosis infection and disease in The Gambia Ifedayo Adetifa,Martin Ota, Abdulrahman Hammond, Moses Lugos,Owiafe
More informationQuantiFERON -TB Gold In-Tube:
QuantiFERON -TB Gold In-Tube: A 7-year Experience at the Bellvitge University Hospital. Dr. Miguel Santín Department of Infectious Diseases Bellvitge University Hospital University of Barcelona 2nd Symposium
More informationShould IGRAs replace the TST?
Should IGRAs replace the TST? Jim Rothel Melbourne, Australia Disclaimer: I am a consultant to Cellestis, a QIAGEN company Presentation Outline Comparative performance of QFT and the TST Is the TST / QFT
More informationInterferon Gamma Release Assay and Tuberculin Skin Test in the Diagnosis of Latent Tuberculosis among Health Care Workers A Comparative Study
International Journal of Current Microbiology and Applied Sciences ISSN: 2319-7706 Volume 6 Number 6 (2017) pp. 2360-2368 Journal homepage: http://www.ijcmas.com Original Research Article https://doi.org/10.20546/ijcmas.2017.606.280
More informationIGRAs Utility in high and low burden settings NDWG meeting, Lille, 2011
IGRAs Utility in high and low burden settings NDWG meeting, Lille, 2011 Keertan Dheda, MB.BCh, FCP(SA), FCCP, FRCP (Lond), PhD (Lond) Professor and Head: Lung Infection and Immunity Unit Division of Pulmonology
More informationDepartment of Medical Statistics, Leiden University Medical Center, Leiden, The. KNCV Tuberculosis Foundation, The Hague, The Netherlands
CVI Accepts, published online ahead of print on August 00 Clin. Vaccine Immunol. doi:0./cvi.00-0 Copyright 00, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved.
More informationEvaluating Diagnostic Tests in the Absence of a Gold Standard
Evaluating Diagnostic Tests in the Absence of a Gold Standard Nandini Dendukuri Departments of Medicine & Epidemiology, Biostatistics and Occupational Health, McGill University; Technology Assessment Unit,
More informationIGRAs in Diagnosis of Childhood LTBI and Active TB: Yes
IGRAs in Diagnosis of Childhood LTBI and Active TB: Yes Professor Ajit Lalvani Director, Tuberculosis Research Unit National Heart and Lung Institute Imperial College London Conflict of Interest Statement:
More informationStatistical approaches for dealing with imperfect reference standards
Statistical approaches for dealing with imperfect reference standards Nandini Dendukuri Departments of Medicine & Epidemiology, Biostatistics and Occupational Health, McGill University; Technology Assessment
More informationMay Billing and Compliance. Hematology. Immunohistochemistry. Immunology. Microbiology. Referral Testing. Supplies
May 2018 Billing and Compliance Glomerular basement membrane, IgG assay CPT code Hematology Differential reporting changes Immunohistochemistry Anaplastic lymphoma kinas (ALK) therapeutic update Multiple
More informationFAQs for Laboratory Professionals
FAQs for Laboratory Professionals QuantiFERON -TB Gold Plus Sample to Insight Contents Questions and answers 3 Test principle 3 Blood collection 4 The blood hasn t reached the black mark on the side of
More informationFAQs for Laboratory Professionals. QuantiFERON -TB Gold
FAQs for Laboratory Professionals QuantiFERON -TB Gold Questions and answers These Frequently Asked Questions (FAQs) relate to the QuantiFERON -TB Gold (QFT ) assay. The answers provided are meant to act
More informationUpdate on the TESEC trials Development of a novel Mtb skin test
ESM Brasov 2012 TALLER UITB-2013 Update on the TESEC trials Development of a novel Mtb skin test Søren Tetens Hoff MD, PhD. Research Scientist Human Immunology Department of Infectious Disease Immunology
More informationPredicting Progression to Tuberculosis Disease in Young Children. Amina Ahmed, MD Levine Children s Hospital March 2, 2018
Predicting Progression to Tuberculosis Disease in Young Children Amina Ahmed, MD Levine Children s Hospital March 2, 2018 Children Are Our Future Diagnosis and treatment of latent tuberculosis infection
More informationLabs, Ledgers, and Lives Saved: The Impact of Diagnostic Strategies on the Epidemiology and Economics of Tuberculosis
Labs, Ledgers, and Lives Saved: The Impact of Diagnostic Strategies on the Epidemiology and Economics of Tuberculosis David Dowdy, MD, PhD 9 th National Conference on Laboratory Aspects of Tuberculosis
More informationEvidence-based TB Diagnosis: how evidence informs practice and policy Madhukar Pai, MD, PhD
Evidence-based TB Diagnosis: how evidence informs practice and policy Madhukar Pai, MD, PhD Assistant Professor, McGill University, Montreal Co-Chair, Evidence Subgroup, New Diagnostics Working Group 1
More informationGSI Equine IL-10 ELISA Kit- Cell Lysate DataSheet
IL-10, also known as human cytokine synthesis inhibitory factor (CSIF), is an antiinflammatory cytokine that is produced by T cells, NK cells, mast cells and macrophages (1,2,3). It is capable of inhibiting
More informationThe International Haemostasis External Quality Control Program
The International Haemostasis External Quality Control Program Intended use of Quality Control Primary Purpose of the Clinical Laboratory To produce accurate results that will correctly diagnose and interpret
More informationGSI Canine IL-10 ELISA Kit DataSheet
IL-10, also known as human cytokine synthesis inhibitory factor (CSIF), is an anti-inflammatory cytokine that is produced by T cells, NK cells, mast cells and macrophages (1,2,3). It is capable of inhibiting
More informationGSI Canine IL-12 ELISA Kit DataSheet
Interleukin 12 (IL12) is the founding member of the IL12 family of heterodimeric cytokines, which have important immunological functions. IL12 is composed of two disulfidelinked subunits of 35 kda and
More informationElectric Forward Market Report
Mar-01 Mar-02 Jun-02 Sep-02 Dec-02 Mar-03 Jun-03 Sep-03 Dec-03 Mar-04 Jun-04 Sep-04 Dec-04 Mar-05 May-05 Aug-05 Nov-05 Feb-06 Jun-06 Sep-06 Dec-06 Mar-07 Jun-07 Sep-07 Dec-07 Apr-08 Jun-08 Sep-08 Dec-08
More informationImmunological Techniques in Research and Clinical Medicine. Philip L. Cohen, M.D. Chief of Rheumatology, LKSOM 10 March 2016
Immunological Techniques in Research and Clinical Medicine Philip L. Cohen, M.D. Chief of Rheumatology, LKSOM 10 March 2016 Antibodies Remarkable Tools for Research and Diagnosis You can make an antibody
More informationOriginal Article INTRODUCTION. Wonju , Korea 2 Institute of Life Science and Biotechnology, Yonsei University, Seoul , Korea
J. Exp. Biomed. Sci. 013, 19(): 90~97 pissn : 1738-36 Original Article Comparison of Mycobacterium tuberculosis Specific Antigen Stimulation Time for Performing Interferon Gamma mrna Assay for Detecting
More informationFDA, Center for Devices & Radiological Health: Microbiology Devices Panel Meeting. June 29 th, 2011 Summary: Carol D. Hamilton MD
FDA, Center for Devices & Radiological Health: Microbiology Devices Panel Meeting June 29 th, 2011 Summary: Carol D. Hamilton MD Disclaimer: I am not an FDA employee nor am I speaking in any official capacity
More informationStrategies for Assessment of Immunotoxicology in Preclinical Drug Development
Strategies for Assessment of Immunotoxicology in Preclinical Drug Development Rebecca Brunette, PhD Scientist, Analytical Biology SNBL USA Preclinical Immunotoxicology The study of evaluating adverse effects
More informationDiscordance of Tuberculin Skin Test and Interferon Gamma Release Assay in Recently Exposed Household Contacts of Pulmonary TB Cases in Brazil
Discordance of Tuberculin Skin Test and Interferon Gamma Release Assay in Recently Exposed Household Contacts of Pulmonary TB Cases in Brazil Rodrigo Ribeiro-Rodrigues 1, Soyeon Kim 2, Flávia Dias Coelho
More informationImmunology 101: Implications for Medical Device Failure. Joshua B. Slee, PhD Assistant Professor of Biology
Immunology 101: Implications for Medical Device Failure Joshua B. Slee, PhD Assistant Professor of Biology Learning Goals Understand innate and adaptive immunity Explain how innate and adaptive immunity
More informationNori Monkey IFN ELISA Kit DataSheet
IFN-γ is a dimerized soluble cytokine that is the only member of the type II class of interferons (1). It plays key roles in both the innate and adaptive immune response against viral and intracellular
More informationNori TM Human IL-17C ELISA Kit-DataSheet
Interleukin 17 is a cytokine that acts as a potent mediator in delayed-type reactions by increasing chemokine production in various tissues to recruit monocytes and neutrophils to the site of inflammation.
More informationHigh Sensitive Rat Leptin ELISA
High Sensitive Rat Leptin ELISA For the high sensitive quantitative determination of Leptin in rat serum or plasma. Cat. No. KT-379 For Research Use Only. 1 Rev. 091707 PRODUCT INFORMATION High Sensitive
More informationTuberculin Skin Test and Boosted Reactions among Newly Employed Healthcare Workers: An Observational Study
Tuberculin Skin Test and Boosted Reactions among Newly Employed Healthcare Workers: An Observational Study Song Yee Kim 1, Moo Suk Park 1, Young Sam Kim 1, Se Kyu Kim 1, Joon Chang 1, Dongeun Yong 2, Hyun
More informationNew insights into sepsis induced renal injury. Indiana University
New insights into sepsis induced renal injury Pi C D h MD Pierre C. Dagher, MD Indiana University Fact Sepsis and septic shock remain the most important cause of Acute Kidney Injury (AKI) in critically
More informationGSI Equine TLR1 ELISA Kit- Plasma/Serum DataSheet
TLR 1 is a member of the Toll-like receptor family (TLR) of pattern recognition receptors of the innate immune system (1,2). TLR1 recognizes pathogen-associated molecular pattern with a specificity for
More informationGSI Equine TNF alpha ELISA Kit- Whole Blood DataSheet
GSI Equine TNF alpha ELISA Kit- Whole Blood DataSheet TNF-α, the prototypical member of the TNF protein superfamily, is a homotrimeric type-ii membrane protein (1,2). Membrane bound TNF-α is cleaved by
More informationTB Intensive San Antonio, Texas
TB Intensive San Antonio, Texas April 6-8, 2011 Genotyping Basics for the Clinician Lisa Armitige, MD, PhD Wednesday April 6,2011 Lisa Armitige, MD, PhD has the following disclosures to make: No conflict
More information7/24/2014. Scientifically driven proof of principle trials: Current and future value to drug development. Disclosure Information
July 24, 2014 Scientifically driven proof of principle trials: Current and future value to drug development Elizabeth M. Jaffee, M.D. Dana and Albert Broccoli Professor of Oncology Skip Viragh Pancreatic
More informationScreening for latent tuberculosis infection: performance of tuberculin skin test and interferon-γ release assays under real-life conditions
EXTENDED REPORT Screening for latent tuberculosis infection: performance of tuberculin skin test and interferon-γ release assays under real-life conditions S Kleinert, 1 H-P Tony, 1 K Krueger, 2 J Detert,
More informationHuman IL-6 EasyTest TM ELISA Kit
BioAim Scientific Inc Human IL-6 EasyTest TM ELISA Kit Cat.No: 1010018 Instruction Manual For research use only TABLE OF CONTENTS I. INTRODUCTION.......3 II. MATERIALS SUPPLIED 4 III. STORAGE....4 IV.
More informationTB Intensive San Antonio, Texas May 7-10, 2013
TB Intensive San Antonio, Texas May 7-10, 2013 Genotyping Lisa Armitige, MD, PhD May 08, 2013 Lisa Armitige, MD, PhD has the following disclosures to make: No conflict of interests No relevant financial
More informationMOLECULAR TESTING: VERIFYING/VALIDATING INSTRUMENTS, REAGENTS AND ASSAYS. Richard L. Hodinka, Ph.D.
MOLECULAR TESTING: VERIFYING/VALIDATING INSTRUMENTS, REAGENTS AND ASSAYS Richard L. Hodinka, Ph.D. University of South Carolina School of Medicine Greenville Greenville Health System, Greenville, SC hodinka@greenvillemed.sc.edu
More informationBIOCOTE. BioCote treatment reduces contamination of laboratory equipment. Introduction
BIOCOTE BioCote treatment reduces contamination of laboratory Introduction Safety in the laboratory is based on the principles of good laboratory practice (GLP) (1). GLP is modified according to the type
More informationMSD MULTI-SPOT Assay System
MSD MULTI-SPOT Assay System Mouse ProInflammatory 7-Plex Ultra-Sensitive Kit 1-Plate Kit 5-Plate Kit 25-Plate Kit K15012C-1 K15012C-2 K15012C-4 17709-v2-2012Mar 1 MSD Biomarker Assays Mouse ProInflammatory
More informationDennis Williams, MD Kentucky Blood Center University of Kentucky Dept. Path and Lab Med
Dennis Williams, MD Kentucky Blood Center University of Kentucky Dept. Path and Lab Med None Disclosures Objectives 1) Describe the FDA Draft Guidance Background and Requirements 2) Review the responsibilities
More informationORIGINAL INVESTIGATION. Cost-effectiveness of Interferon Gamma Release Assays vs Tuberculin Skin Tests in Health Care Workers. (HCWs) are at increased
ORIGINAL INVESTIGATION Cost-effectiveness of Interferon Gamma Release Assays vs Tuberculin Skin Tests in Health Care Workers Marie A. de Perio, MD; Joel Tsevat, MD, MPH; Gary A. Roselle, MD; Stephen M.
More informationCLSI C60: Assay Validation & Post-Validation Monitoring
CLSI C60: Assay Validation & Post-Validation Monitoring Ross J. Molinaro, MT(ASCP), PhD, DABCC, FACB Medical Director Core Laboratory, Emory University Hospital Midtown Emory Clinical Translational Research
More informationThe Second Global Symposium on IGRAs June 1, 2009
Akiko Kowada, MD PhD Director, Department of Health Service Katsushika City Public Health Center, Tokyo, Japan The Second Global Symposium on IGRAs June 1, 2009 Overview Background Study 1: Cost effectiveness
More information510(k) SUBSTANTIAL EQUIVALENCE DETERMINATION DECISION SUMMARY ASSAY ONLY TEMPLATE
510(k) SUBSTANTIAL EQUIVALENCE DETERMINATION DECISION SUMMARY ASSAY ONLY TEMPLATE A. 510(k) Number: k100499 B. Purpose for Submission: New Device C. Measurand: Rheumatoid Factors IgG, IgM and IgA and Rheumatoid
More informationELISPOT antibody pair Technical Data Sheet
ELISPOT antibody pair Technical Data Sheet 10-plate and 20-plate format For research use only. Not for use in diagnostic or therapeutic procedures. This Technical Data Sheet applies for the following U-CyTech
More informationNori Feline IL-17C ELISA Kit-DataSheet
Interleukin 17 is a cytokine that acts as a potent mediator in delayed-type reactions by increasing chemokine production in various tissues to recruit monocytes and neutrophils to the site of inflammation.
More informationImmunogenicity: Assessing the Clinical Relevance and Risk Minimization of Antibodies to Biopharmaceuticals
Immunogenicity: Assessing the Clinical Relevance and Risk Minimization of Antibodies to Biopharmaceuticals Daniel Kramer/Kathleen Beach Need for public-private collaboration 1 All biopharmaceuticals are
More informationNational Reference Laboratory Quality Assurance Dashboard. Quality Improvement Metrics Q2 2017
National Reference Laboratory Quality Assurance Dashboard Quality Improvement Metrics Q2 July INTRODUCTION National Reference Laboratory (NRL), part of Mubadala's network of world-class healthcare providers,
More informationNori Feline IL-10 ELISA Kit DataSheet
IL-10, also known as human cytokine synthesis inhibitory factor (CSIF), is an anti-inflammatory cytokine that is produced by T cells, NK cells, mast cells and macrophages (1,2,3). It is capable of inhibiting
More informationHELICA BIOSYSTEMS, INC. HIGH SENSITIVITY HUMAN C-REACTIVE PROTEIN FOR RESEARCH USE ONLY (Not for in vitro diagnostic use)
INTENDED USE HELICA BIOSYSTEMS, INC. HIGH SENSITIVITY HUMAN C-REACTIVE PROTEIN FOR RESEARCH USE ONLY (Not for in vitro diagnostic use) The Helica C-reactive protein assay is intended for the detection
More informationNori Rabbit IL-5 ELISA Kit -2 Plates DataSheet
Interleukin5 (IL5) is a secreted glycoprotein that belongs to the α-helical group of cytokines (1, 2, 3). Unlike other family members, it is present as a covalently linked antiparallel dimer (4, 5). IL-5
More informationNori Rabbit IFN ELISA Kit DataSheet
Nori Rabbit IFN ELISA Kit DataSheet IFN-γ is a dimerized soluble cytokine that is the only member of the type II class of interferons (1). It plays key roles in both the innate and adaptive immune response
More informationNori TM Human IL-17C ELISA Kit-2 plates DataSheet
Interleukin 17 is a cytokine that acts as a potent mediator in delayed-type reactions by increasing chemokine production in various tissues to recruit monocytes and neutrophils to the site of inflammation.
More informationThorny topics related to CRE control
Thorny topics related to CRE control Michael Lin, MD MPH Rush University Medical Center Chicago CDC Prevention Epicenter 19 th Annual Chicago Infection Control Conference May 30, 2014 Disclosures I have
More informationTwo-Dimensional (2D) Vaccine Barcode Pilot Project
Two-Dimensional (2D) Vaccine Barcode Pilot Project Association of Immunization Managers / Immunization Program Managers Meeting February 3, 2012 Ken Gerlach, MPH, CTR Immunization Services Division National
More informationassessment regarding the effects of accuracy checks for infusion and syringe pumps on other clinical operations.
Introduction Materials As per the revised Pharmaceutical Affairs Law announced in July 2004, infusion and syringe pumps are classified as specially controlled medical devices. In our hospital, all infusion
More informationESCMID Online Lecture Library. Molecular diagnosis of malaria. by author
Molecular diagnosis of DNA malaria Aldert Bart Parasitology Medical Microbiology Academic Medical Center Amsterdam ESCMID course 05-06-12 Putative advantages of molecular diagnosis of malaria correct (unequivocal?)
More informationjmb A Homogeneous Immunoassay Method for Detecting Interferon- Gamma in Patients with Latent Tuberculosis Infection Research Article Review
J. Microbiol. Biotechnol. (2016), 26(3), 588 595 http://dx.doi.org/10.4014/jmb.1507.07102 Review Research Article jmb A Homogeneous Immunoassay Method for Detecting Interferon- Gamma in Patients with Latent
More informationHuman IFN-α (Interferon-Alpha) Pre-Coated ELISA Kit
Human IFN-α (Interferon-Alpha) Pre-Coated ELISA Kit Catalog No: 90-2235 1 96 well Format (96 tests) Detection Range: 15.6 1000 pg/ml Sensitivity:
More informationInterplay of Cells involved in Therapeutic Agent Immunogenicity. Robert G. Hamilton, Ph.D., D.ABMLI Professor of Medicine and Pathology
Interplay of Cells involved in Therapeutic Agent Immunogenicity Robert G. Hamilton, Ph.D., D.ABMLI Professor of Medicine and Pathology Disclosure The author works with Amicus on an immunogenicity project
More informationIncorporating New TB Diagnostics into RePORT
Incorporating New TB Diagnostics into RePORT Susan Dorman Johns Hopkins University School of Medicine REPORT MEETING, DURBAN, JULY 2016 MACS designed to: 1. Elucidate the natural history of the infection
More informationLIAISON QuantiFERON Software
Tuberculosis LIAISON QuantiFERON Software Traceable and efficient TB testing FOR OUTSIDE THE US AND CANADA ONLY LIAISON QuantiFERON Software LIAISON QuantiFERON Software (LQS) is a flexible lab tool that
More informationIEDB Overview. Bjoern Peters, Ph.D. Associate Professor IEDB Co-Principal Investigator
IEDB Overview Bjoern Peters, Ph.D. Associate Professor IEDB Co-Principal Investigator 1 The Immune Epitope Database Free online resource of experimentally-derived epitope information T T B Allergens APC
More informationHanford Turlock Woodland
Denele Analytical Since 1968 Joe Mullinax Plant Pathologist Hanford Turlock Woodland Soil H20 Seed Nematodes ELAP Plant Tissue Manure Feeds-Invitro Plant Pathology Environmental Foods Denele Respiration
More informationSupplemental Figure 1
Supplemental Figure 1 A IL-12p7 (pg/ml) 7 6 4 3 2 1 Medium then TLR ligands MDP then TLR ligands Medium then TLR ligands + MDP MDP then TLR ligands + MDP B IL-12p4 (ng/ml) 1.2 1..8.6.4.2. Medium MDP Medium
More informationThe Cat s Out of the Bag: Microbiological Investigations of Acute Transfusion Reactions.
The Cat s Out of the Bag: Microbiological Investigations of Acute Transfusion Reactions. Philippe Lagacé-Wiens, MD FRCPC, DTM&H plagacewiens@sharedhealthmb.ca COI declaration I have no conflicts, real
More informationCompendium of Immune Signatures Identifies Conserved and Species-Specific Biology in Response to Inflammation
Immunity Supplemental Information Compendium of Immune Signatures Identifies Conserved and Species-Specific Biology in Response to Inflammation Jernej Godec, Yan Tan, Arthur Liberzon, Pablo Tamayo, Sanchita
More informationMycobacterial transport medium for routine culture of fine needle aspiration biopsies
Mycobacterial transport medium for routine culture of fine needle aspiration biopsies C A Wright, A Vermaak Divisions of Anatomical Pathology, Department of Pathology, Stellenbosch University and NHLS
More informationThe genetic material is arranged differently in the cells of bacteria compared with animal and plant cells.
Some infections are caused by bacteria. The genetic material is arranged differently in the cells of bacteria compared with animal and plant cells. Describe two differences. Tuberculosis (TB) is an infection
More informationSouthern California CSU DNP Consortium
Southern California CSU DNP Consortium California State University, Fullerton California State University, Long Beach California State University, Los Angeles EVALUATION OF LATENT TUBERCULOSIS INFECTION
More informationTHE HUMAN ELEMENT IN ELECTRONIC HEALTH SYSTEMS: Getting to Zero ARV Stockouts in Kenya
THE HUMAN ELEMENT IN ELECTRONIC HEALTH SYSTEMS: Getting to Zero ARV Stockouts in Kenya RUTH NJOROGE, CHIEF OF PARTY, USAID KENYA PHARMA PROJECT CHEMONICS INTERNATIONAL PRESENTER DISCLOSURES Ruth Njoroge
More informationRayBio Human TIMP-2 ELISA Kit
RayBio Human TIMP-2 ELISA Kit User Manual (Revised Mar 1, 2012) RayBio Human TIMP-2 ELISA Kit Protocol (Cat#: ELH-TIMP2-001) RayBiotech, Inc. We Provide You With Excellent Protein Array System And Service
More informationLaboratory Testing Issues for Protein C, Protein S and Antithrombin Assays
Laboratory Testing Issues for Protein C, Protein S and Antithrombin Assays Richard A. Marlar Ph.D. University of Oklahoma THSNA Meeting- Chicago, IL April 14-16, 2016 DISCLOSURE Richard A. Marlar, PhD
More informationUsing Big Data to Improve Clinical Quality at Kaiser Permanente, Southern California
Using Big Data to Improve Clinical Quality at Kaiser Permanente, Southern California Presentation to the Canadian Medical Protective Association at the Information Session of the Annual Meeting August
More informationHuman IL-6 ELISA Kit. User Manual (Revised Dec 16, 2009) Human IL-6 ELISA Kit Protocol. (Cat#: RAY-ELH-IL6-001)
Li StarFish S.r.l. Via Cavour, 35-20063 Cernusco S/N (MI), Italy Tel. +39-02-92150794 - Fax. +39-02-92157285 info@listarfish.it -www.listarfish.it Human IL-6 ELISA Kit User Manual (Revised Dec 16, 2009)
More informationPaper ref: TB (04/19) 016
Paper ref: TB (04/19) 016 Report Title Workforce and pay bill phasing and Fully Staffed scorecard Sponsoring Executive Raffaela Goodby Director of People and Organisation Development Author Raffaela Goodby
More informationVeriKine-HS TM Mouse IFN Beta Serum ELISA Kit
VeriKine-HS TM Mouse IFN Beta Serum ELISA Kit Catalog No. 42410 Assay Range: 0.94 60 pg/ml Store all components at 2-8 o C Sold under license from Pestka Biomedical Laboratories, Inc. d/b/a PBL Assay Science.
More information2017 KEY INSIGHTS ON. Employee Attendance and Tardiness
2017 KEY INSIGHTS ON Employee Attendance and Tardiness THE AVERAGE NUMBER OF MINUTES THAT EMPLOYEES IN THE XIMBLE SYSTEM ARE LATE IS MINUTES. 114.2 MINUTES Statistical sample of 263258 clock-in records,
More informationCarcinoembryonic Antigen (CEA) ELISA Kit Protocol. (Cat. No.:EK )
Carcinoembryonic Antigen (CEA) ELISA Kit Protocol (Cat. No.:EK-310-11) 330 Beach Road, Burlingame CA Tel: 650-558-8898 Fax: 650-558-1686 E-Mail: info@phoenixpeptide.com www.phoenixpeptide.com INTENDED
More informationCD1a-autoreactive T cells are a normal component of the human αβ T cell repertoire
CDa-autoreactive T cells are a normal component of the human αβ T cell repertoire Annemieke de Jong, Victor Peña-Cruz, Tan-Yun Cheng, Rachael A. Clark, Ildiko Van Rhijn,, D. Branch Moody Division of Rheumatology,
More informationMid-recruitment trial redesign to incorporate genetic sub-types: the PICCOLO Trial
Mid-recruitment trial redesign to incorporate genetic sub-types: the PICCOLO Trial Sarah Brown Catherine Olivier On behalf of the PICCOLO Trial Team Society for Clinical Trials May 15-18, 2011 Vancouver,
More informationConsiderations in Product Development with Advanced Therapies and Cancer Vaccines
Considerations in Product Development with Advanced Therapies and Cancer Vaccines Thomas Hinz Head of Section Therapeutic Vaccines Paul-Ehrlich-Institut hinth@pei.de Thomas Hinz, October 29, 2008, San
More information